Haiyan Yang

机构：Central South University, Chongqing University, Northwestern Polytechnical University, Shanghai Jiao Tong University, Zhejiang Cancer Hospital, Hunan Cancer Hospital, First People’s Hospital of Zunyi, Affiliated Hospital of Zunyi Medical College, Hangzhou Cancer Hospital, Wuhan Institute of Technology · ORCID：0000-0001-5185-4696

发表论文 144 篇 · 总被引 2288 次 · h-index 24

代表论文

• Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study (2025 · The Lancet Oncology · 被引 49)
• Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma (2024 · Translational Oncology · 被引 16)
• Liposomal mitoxantrone monotherapy in patients with relapsed or refractory mature T‐cell and natural killer‐cell neoplasms: A phase 2, multicenter, open‐label, single‐arm trial (2025 · Cancer · 被引 11)
• Boosting hydrogen storage performances of MgH2 by using a Ni-MOF derived Ni/NiO@C composite containing Ni/NiO nanoheterojunctions (2025 · Chemical Engineering Journal · 被引 6)
• Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial (2024 · Journal for ImmunoTherapy of Cancer · 被引 6)
• Efficacy and safety of rocbrutinib, a highly selective 4th-generation BTK inhibitor, in Chinese patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2025 · Blood · 被引 3)